Part 1
Part 2
Part 3
Part 5
Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. Market Analysis and Insights: Global and United States Anti-Inflammatory Cytokine Market
This report focuses on global and United States Anti-Inflammatory Cytokine market, also covers the segmentation data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cardiovascular Diseases was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Anti-Inflammatory Cytokine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Anti-Inflammatory Cytokine Scope and Market Size Anti-Inflammatory Cytokine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-Inflammatory Cytokine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Anti-Inflammatory Cytokine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Oral Intravenous Others Segment by Application Cardiovascular Diseases Osteoarthritis Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE By Company Merck KGaA Eli Lilly and Company Pfizer Inc. Sanofi S.A. Novartis AG Hoffmann-La Roche Ltd. Lonza Group Ltd. Thermo Fisher Scientific Meridian Bioscience Inc. General Electric Company Abcam PLC GenScript Biotech Corp Applied Biological Materials Inc. Randox Laboratories
1 Study Coverage
1.1 Anti-Inflammatory Cytokine Product Introduction
1.2 Global Anti-Inflammatory Cytokine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Inflammatory Cytokine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Inflammatory Cytokine Sales in Volume for the Year 2017-2028
1.3 United States Anti-Inflammatory Cytokine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Inflammatory Cytokine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Inflammatory Cytokine Sales in Volume for the Year 2017-2028
1.4 Anti-Inflammatory Cytokine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Inflammatory Cytokine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Inflammatory Cytokine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Inflammatory Cytokine Market Dynamics
1.5.1 Anti-Inflammatory Cytokine Industry Trends
1.5.2 Anti-Inflammatory Cytokine Market Drivers
1.5.3 Anti-Inflammatory Cytokine Market Challenges
1.5.4 Anti-Inflammatory Cytokine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anti-Inflammatory Cytokine Market Segment by Type
2.1.1 Oral
2.1.2 Intravenous
2.1.3 Others
2.2 Global Anti-Inflammatory Cytokine Market Size by Type
2.2.1 Global Anti-Inflammatory Cytokine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Inflammatory Cytokine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Inflammatory Cytokine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Inflammatory Cytokine Market Size by Type
2.3.1 United States Anti-Inflammatory Cytokine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Inflammatory Cytokine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Inflammatory Cytokine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anti-Inflammatory Cytokine Market Segment by Application
3.1.1 Cardiovascular Diseases
3.1.2 Osteoarthritis
3.1.3 Others
3.2 Global Anti-Inflammatory Cytokine Market Size by Application
3.2.1 Global Anti-Inflammatory Cytokine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Inflammatory Cytokine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Inflammatory Cytokine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Inflammatory Cytokine Market Size by Application
3.3.1 United States Anti-Inflammatory Cytokine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Inflammatory Cytokine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Inflammatory Cytokine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anti-Inflammatory Cytokine Competitor Landscape by Company
4.1 Global Anti-Inflammatory Cytokine Market Size by Company
4.1.1 Top Global Anti-Inflammatory Cytokine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Inflammatory Cytokine Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Inflammatory Cytokine Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Inflammatory Cytokine Price by Manufacturer (2017-2022)
4.2 Global Anti-Inflammatory Cytokine Concentration Ratio (CR)
4.2.1 Anti-Inflammatory Cytokine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Inflammatory Cytokine in 2021
4.2.3 Global Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Inflammatory Cytokine Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Inflammatory Cytokine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Inflammatory Cytokine Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Inflammatory Cytokine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Inflammatory Cytokine Market Size by Company
4.5.1 Top Anti-Inflammatory Cytokine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Inflammatory Cytokine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Inflammatory Cytokine Sales by Players (2020, 2021 & 2022)
5 Global Anti-Inflammatory Cytokine Market Size by Region
5.1 Global Anti-Inflammatory Cytokine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Inflammatory Cytokine Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Inflammatory Cytokine Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Inflammatory Cytokine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Inflammatory Cytokine Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Inflammatory Cytokine Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Inflammatory Cytokine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Inflammatory Cytokine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Corporation Information
7.1.2 Merck KGaA Description and Business Overview
7.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck KGaA Anti-Inflammatory Cytokine Products Offered
7.1.5 Merck KGaA Recent Development
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporation Information
7.2.2 Eli Lilly and Company Description and Business Overview
7.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Products Offered
7.2.5 Eli Lilly and Company Recent Development
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporation Information
7.3.2 Pfizer Inc. Description and Business Overview
7.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Products Offered
7.3.5 Pfizer Inc. Recent Development
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Corporation Information
7.4.2 Sanofi S.A. Description and Business Overview
7.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Products Offered
7.4.5 Sanofi S.A. Recent Development
7.5 Novartis AG
7.5.1 Novartis AG Corporation Information
7.5.2 Novartis AG Description and Business Overview
7.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis AG Anti-Inflammatory Cytokine Products Offered
7.5.5 Novartis AG Recent Development
7.6 Hoffmann-La Roche Ltd.
7.6.1 Hoffmann-La Roche Ltd. Corporation Information
7.6.2 Hoffmann-La Roche Ltd. Description and Business Overview
7.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Products Offered
7.6.5 Hoffmann-La Roche Ltd. Recent Development
7.7 Lonza Group Ltd.
7.7.1 Lonza Group Ltd. Corporation Information
7.7.2 Lonza Group Ltd. Description and Business Overview
7.7.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Products Offered
7.7.5 Lonza Group Ltd. Recent Development
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporation Information
7.8.2 Thermo Fisher Scientific Description and Business Overview
7.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Products Offered
7.8.5 Thermo Fisher Scientific Recent Development
7.9 Meridian Bioscience Inc.
7.9.1 Meridian Bioscience Inc. Corporation Information
7.9.2 Meridian Bioscience Inc. Description and Business Overview
7.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Products Offered
7.9.5 Meridian Bioscience Inc. Recent Development
7.10 General Electric Company
7.10.1 General Electric Company Corporation Information
7.10.2 General Electric Company Description and Business Overview
7.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 General Electric Company Anti-Inflammatory Cytokine Products Offered
7.10.5 General Electric Company Recent Development
7.11 Abcam PLC
7.11.1 Abcam PLC Corporation Information
7.11.2 Abcam PLC Description and Business Overview
7.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Abcam PLC Anti-Inflammatory Cytokine Products Offered
7.11.5 Abcam PLC Recent Development
7.12 GenScript Biotech Corp
7.12.1 GenScript Biotech Corp Corporation Information
7.12.2 GenScript Biotech Corp Description and Business Overview
7.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GenScript Biotech Corp Products Offered
7.12.5 GenScript Biotech Corp Recent Development
7.13 Applied Biological Materials Inc.
7.13.1 Applied Biological Materials Inc. Corporation Information
7.13.2 Applied Biological Materials Inc. Description and Business Overview
7.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Applied Biological Materials Inc. Products Offered
7.13.5 Applied Biological Materials Inc. Recent Development
7.14 Randox Laboratories
7.14.1 Randox Laboratories Corporation Information
7.14.2 Randox Laboratories Description and Business Overview
7.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Randox Laboratories Products Offered
7.14.5 Randox Laboratories Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anti-Inflammatory Cytokine Industry Chain Analysis
8.2 Anti-Inflammatory Cytokine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Inflammatory Cytokine Distributors
8.3 Anti-Inflammatory Cytokine Production Mode & Process
8.4 Anti-Inflammatory Cytokine Sales and Marketing
8.4.1 Anti-Inflammatory Cytokine Sales Channels
8.4.2 Anti-Inflammatory Cytokine Distributors
8.5 Anti-Inflammatory Cytokine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Anti-Inflammatory Cytokine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Anti-Inflammatory Cytokine Market Trends Table 3. Anti-Inflammatory Cytokine Market Drivers Table 4. Anti-Inflammatory Cytokine Market Challenges Table 5. Anti-Inflammatory Cytokine Market Restraints Table 6. Global Anti-Inflammatory Cytokine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Anti-Inflammatory Cytokine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Anti-Inflammatory Cytokine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Anti-Inflammatory Cytokine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Anti-Inflammatory Cytokine Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Anti-Inflammatory Cytokine Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Anti-Inflammatory Cytokine Revenue Share by Manufacturer, 2017-2022 Table 13. Global Anti-Inflammatory Cytokine Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Anti-Inflammatory Cytokine Sales Share by Manufacturer, 2017-2022 Table 15. Global Anti-Inflammatory Cytokine Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Anti-Inflammatory Cytokine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Anti-Inflammatory Cytokine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory Cytokine as of 2021) Table 18. Top Players of Anti-Inflammatory Cytokine in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Anti-Inflammatory Cytokine Product Type Table 20. Date of International Manufacturers Enter into Anti-Inflammatory Cytokine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Anti-Inflammatory Cytokine Players in United States Market, Ranking by Revenue (2021) Table 23. United States Anti-Inflammatory Cytokine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Anti-Inflammatory Cytokine Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Anti-Inflammatory Cytokine Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Anti-Inflammatory Cytokine Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Anti-Inflammatory Cytokine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Anti-Inflammatory Cytokine Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Anti-Inflammatory Cytokine Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Anti-Inflammatory Cytokine Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Anti-Inflammatory Cytokine Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Anti-Inflammatory Cytokine Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Anti-Inflammatory Cytokine Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Merck KGaA Corporation Information Table 43. Merck KGaA Description and Business Overview Table 44. Merck KGaA Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Merck KGaA Anti-Inflammatory Cytokine Product Table 46. Merck KGaA Recent Development Table 47. Eli Lilly and Company Corporation Information Table 48. Eli Lilly and Company Description and Business Overview Table 49. Eli Lilly and Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Eli Lilly and Company Product Table 51. Eli Lilly and Company Recent Development Table 52. Pfizer Inc. Corporation Information Table 53. Pfizer Inc. Description and Business Overview Table 54. Pfizer Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. Pfizer Inc. Product Table 56. Pfizer Inc. Recent Development Table 57. Sanofi S.A. Corporation Information Table 58. Sanofi S.A. Description and Business Overview Table 59. Sanofi S.A. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Sanofi S.A. Product Table 61. Sanofi S.A. Recent Development Table 62. Novartis AG Corporation Information Table 63. Novartis AG Description and Business Overview Table 64. Novartis AG Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Novartis AG Product Table 66. Novartis AG Recent Development Table 67. Hoffmann-La Roche Ltd. Corporation Information Table 68. Hoffmann-La Roche Ltd. Description and Business Overview Table 69. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Hoffmann-La Roche Ltd. Product Table 71. Hoffmann-La Roche Ltd. Recent Development Table 72. Lonza Group Ltd. Corporation Information Table 73. Lonza Group Ltd. Description and Business Overview Table 74. Lonza Group Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. Lonza Group Ltd. Product Table 76. Lonza Group Ltd. Recent Development Table 77. Thermo Fisher Scientific Corporation Information Table 78. Thermo Fisher Scientific Description and Business Overview Table 79. Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Thermo Fisher Scientific Product Table 81. Thermo Fisher Scientific Recent Development Table 82. Meridian Bioscience Inc. Corporation Information Table 83. Meridian Bioscience Inc. Description and Business Overview Table 84. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. Meridian Bioscience Inc. Product Table 86. Meridian Bioscience Inc. Recent Development Table 87. General Electric Company Corporation Information Table 88. General Electric Company Description and Business Overview Table 89. General Electric Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. General Electric Company Product Table 91. General Electric Company Recent Development Table 92. Abcam PLC Corporation Information Table 93. Abcam PLC Description and Business Overview Table 94. Abcam PLC Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Abcam PLC Product Table 96. Abcam PLC Recent Development Table 97. GenScript Biotech Corp Corporation Information Table 98. GenScript Biotech Corp Description and Business Overview Table 99. GenScript Biotech Corp Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. GenScript Biotech Corp Product Table 101. GenScript Biotech Corp Recent Development Table 102. Applied Biological Materials Inc. Corporation Information Table 103. Applied Biological Materials Inc. Description and Business Overview Table 104. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Applied Biological Materials Inc. Product Table 106. Applied Biological Materials Inc. Recent Development Table 107. Randox Laboratories Corporation Information Table 108. Randox Laboratories Description and Business Overview Table 109. Randox Laboratories Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. Randox Laboratories Product Table 111. Randox Laboratories Recent Development Table 112. Key Raw Materials Lists Table 113. Raw Materials Key Suppliers Lists Table 114. Anti-Inflammatory Cytokine Customers List Table 115. Anti-Inflammatory Cytokine Distributors List Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Inflammatory Cytokine Product Picture Figure 2. Global Anti-Inflammatory Cytokine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Anti-Inflammatory Cytokine Market Size 2017-2028 (US$ Million) Figure 4. Global Anti-Inflammatory Cytokine Sales 2017-2028 (K Units) Figure 5. United States Anti-Inflammatory Cytokine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Anti-Inflammatory Cytokine Market Size 2017-2028 (US$ Million) Figure 7. United States Anti-Inflammatory Cytokine Sales 2017-2028 (K Units) Figure 8. United States Anti-Inflammatory Cytokine Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Anti-Inflammatory Cytokine Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Anti-Inflammatory Cytokine Report Years Considered Figure 11. Product Picture of Oral Figure 12. Product Picture of Intravenous Figure 13. Product Picture of Others Figure 14. Global Anti-Inflammatory Cytokine Market Share by Type in 2022 & 2028 Figure 15. Global Anti-Inflammatory Cytokine Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Type (2017-2028) Figure 17. Global Anti-Inflammatory Cytokine Sales by Type (2017-2028) & (K Units) Figure 18. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Anti-Inflammatory Cytokine Price by Type (2017-2028) & (US$/Unit) Figure 20. United States Anti-Inflammatory Cytokine Market Share by Type in 2022 & 2028 Figure 21. United States Anti-Inflammatory Cytokine Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Anti-Inflammatory Cytokine Sales Market Share in Value by Type (2017-2028) Figure 23. United States Anti-Inflammatory Cytokine Sales by Type (2017-2028) & (K Units) Figure 24. United States Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Anti-Inflammatory Cytokine Price by Type (2017-2028) & (US$/Unit) Figure 26. Product Picture of Cardiovascular Diseases Figure 27. Product Picture of Osteoarthritis Figure 28. Product Picture of Others Figure 29. Global Anti-Inflammatory Cytokine Market Share by Application in 2022 & 2028 Figure 30. Global Anti-Inflammatory Cytokine Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2017-2028) Figure 32. Global Anti-Inflammatory Cytokine Sales by Application (2017-2028) & (K Units) Figure 33. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Anti-Inflammatory Cytokine Price by Application (2017-2028) & (US$/Unit) Figure 35. United States Anti-Inflammatory Cytokine Market Share by Application in 2022 & 2028 Figure 36. United States Anti-Inflammatory Cytokine Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2017-2028) Figure 38. United States Anti-Inflammatory Cytokine Sales by Application (2017-2028) & (K Units) Figure 39. United States Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Anti-Inflammatory Cytokine Price by Application (2017-2028) & (US$/Unit) Figure 41. North America Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 42. North America Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. United States Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 46. Europe Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 53. Asia-Pacific Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. China Taiwan Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 69. Middle East & Africa Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. UAE Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Anti-Inflammatory Cytokine Value Chain Figure 74. Anti-Inflammatory Cytokine Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed
Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. Market Analysis and Insights: Global and United States Anti-Inflammatory Cytokine Market
This report focuses on global and United States Anti-Inflammatory Cytokine market, also covers the segmentation data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cardiovascular Diseases was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Anti-Inflammatory Cytokine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Anti-Inflammatory Cytokine Scope and Market Size Anti-Inflammatory Cytokine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-Inflammatory Cytokine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Anti-Inflammatory Cytokine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Oral Intravenous Others Segment by Application Cardiovascular Diseases Osteoarthritis Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE By Company Merck KGaA Eli Lilly and Company Pfizer Inc. Sanofi S.A. Novartis AG Hoffmann-La Roche Ltd. Lonza Group Ltd. Thermo Fisher Scientific Meridian Bioscience Inc. General Electric Company Abcam PLC GenScript Biotech Corp Applied Biological Materials Inc. Randox Laboratories
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now